| Analysis | Metabolite Name | Measured Value | Units | Genotype | TREATMENT | TIME_POINT |
|---|---|---|---|---|---|---|
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.130057181 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.301558039 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.355551459 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.446410366 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.482109153 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.483297049 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.498234601 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.591043533 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.700506363 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.720720538 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.726716356 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.74008537 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.744704169 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.75782274 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.78201674 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.857303537 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.866749511 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.88806091 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.894847893 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.910786374 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.923110716 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.975067334 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.996875139 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.056440073 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.067327872 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.095524663 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.173008463 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.179460718 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.186244681 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.20204969 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.208549188 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.221356781 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.230935622 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.249600987 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.338736929 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.424468342 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.494632284 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.582956767 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.603082004 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.977024355 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|